Davidar David D 4

What Happened

• Davidar David D, a director of Globus Medical, was granted a derivative award of 15,000 shares (reported as options/awards) on January 21, 2026. The filing reports an acquisition at $0.00 (derivative), so no cash changed hands at grant. The award is subject to vesting and is reported as having a $0.00 immediate value in the Form 4.

Key Details

• Transaction date: January 21, 2026; Form 4 filed January 23, 2026 (timely filing).
• Transaction type: Grant / award of derivative securities (code A).
• Quantity: 15,000 shares/options granted; reported price $0.00 in the filing.
• Vesting: These options were granted on January 21, 2026, and will vest on January 1, 2027 (footnote F1).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Filing timeliness: Filed two days after the transaction date, consistent with Form 4 deadlines.

Context

• This is a compensation grant to a director, not an open-market buy or sale. Awards that vest in the future are common for director compensation and do not by themselves indicate immediate buying or selling activity.
• The filing does not show an exercise, sale, or cashless transaction; it simply records the grant and the vesting schedule.